Cargando…
Curcumin Enhances the Anticancer Effects of Binimetinib on Melanoma Cells by Inducing Mitochondrial Dysfunction and Cell Apoptosis with Necroptosis
BACKGROUND: Recent studies suggest that MEK1/2 inhibitors, including binimetinib, significantly improve malignant melanoma (MM) patient survival. Growing evidence suggests that phytochemicals, especially curcumin, can overcome drug resistance in cancer cells through a variety of mechanisms. OBJECTIV...
Autores principales: | Lee, Yoon Jin, Heo, Jae Young, Kim, Dong Sung, Choi, Yu Sung, Kim, Sooyoung, Nam, Hae Seon, Lee, Sang Han, Cho, Moon Kyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258547/ https://www.ncbi.nlm.nih.gov/pubmed/37290955 http://dx.doi.org/10.5021/ad.22.200 |
Ejemplares similares
-
Antitumor Effect of Metformin in Combination with Binimetinib on
Melanoma Cells
por: Lee, Eunsung, et al.
Publicado: (2021) -
Apigenin causes necroptosis by inducing ROS accumulation, mitochondrial dysfunction, and ATP depletion in malignant mesothelioma cells
por: Lee, Yoon-Jin, et al.
Publicado: (2020) -
Binimetinib plus encorafenib for metastatic melanoma
Publicado: (2019) -
Encorafenib and Binimetinib Combination Therapy in Metastatic Melanoma
por: Davis, Jessica, et al.
Publicado: (2022) -
Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma
por: Seethapathy, Harish, et al.
Publicado: (2020)